ENDOCYTE INC
DelistedCIK 1235007fmd_0Q00K5YY32HDRV3FV5AR1KYMDPManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2018, 35 periods
Latest annual · FY2017
Millions- Total revenues
- 0
- Operating income
- (56)
- Net income
- (55)
- Free cash flow
- (34)
Latest quarter · Q3 FY2018
Millions- Total revenues
- 0
- Operating income
- (14)
- Net income
- (13)
- Free cash flow
- (16)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2014 to FY2017
- -90.0%
- Revenue, 5 yearsFY2012 to FY2017
- -71.1%
- Net income, 5 yearsFY2012 to FY2017
- n/m
ENDOCYTE INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Revenue | $70,000 | $70,000 | 0% | 10-K 2018-02-27 · proof |
| Operating income | -$56.1 million | -$44.7 million | 10-K 2018-02-27 · proof | |
| Net income | -$55.1 million | -$43.9 million | 10-K 2018-02-27 · proof | |
| Cash from operating activities | -$33.7 million | -$34.7 million | 10-K 2018-02-27 · proof | |
| Free cash flow | -$33.7 million | -$35.4 million | 10-K 2018-02-27 · proof | |
| Total assets | $100.8 million | $143.5 million | -29.8% | 10-K 2018-02-27 · proof |
| Total liabilities | $5.3 million | $6.3 million | -16.8% | 10-K 2018-02-27 · proof |
| Cash and cash equivalents | $18.6 million | $31.2 million | -40.6% | 10-K 2018-02-27 · proof |
- What was ENDOCYTE INC's revenue in fiscal 2017?
- ENDOCYTE INC reported revenue of $70,000 for fiscal 2017 (the year ended Dec 31, 2017), against $70,000 the year before (0%). Source: the 10-K filed with the SEC on Feb 27, 2018. SEC
- What was ENDOCYTE INC's operating income in fiscal 2017?
- ENDOCYTE INC reported operating income of -$56.1 million for fiscal 2017 (the year ended Dec 31, 2017), against -$44.7 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2018. SEC
- What was ENDOCYTE INC's net income in fiscal 2017?
- ENDOCYTE INC reported net income of -$55.1 million for fiscal 2017 (the year ended Dec 31, 2017), against -$43.9 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2018. SEC
- What was ENDOCYTE INC's cash from operating activities in fiscal 2017?
- ENDOCYTE INC reported cash from operating activities of -$33.7 million for fiscal 2017 (the year ended Dec 31, 2017), against -$34.7 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2018. SEC
- What was ENDOCYTE INC's free cash flow in fiscal 2017?
- ENDOCYTE INC reported free cash flow of -$33.7 million for fiscal 2017 (the year ended Dec 31, 2017), against -$35.4 million the year before. Source: the 10-K filed with the SEC on Feb 27, 2018. SEC
- What are ENDOCYTE INC's total assets?
- As of Dec 31, 2017, ENDOCYTE INC reported total assets of $100.8 million, against $143.5 million a year earlier (-29.8%). Source: the 10-K filed with the SEC on Feb 27, 2018. SEC
- What are ENDOCYTE INC's total liabilities?
- As of Dec 31, 2017, ENDOCYTE INC reported total liabilities of $5.3 million, against $6.3 million a year earlier (-16.8%). Source: the 10-K filed with the SEC on Feb 27, 2018. SEC
- What are ENDOCYTE INC's cash and cash equivalents?
- As of Dec 31, 2017, ENDOCYTE INC reported cash and cash equivalents of $18.6 million, against $31.2 million a year earlier (-40.6%). Source: the 10-K filed with the SEC on Feb 27, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1235007&period_type=annual&limit=5"Information only, not investment advice.